32 / 74 · 0:53 · Original AXON film
Pinealon
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
Pinealon | Early-stage research
Pinealon is a three-amino-acid peptide, also called EDR. Its early research asks how stressed cells respond, rather than whether healthy people become sharper. [1]
CELL MODELS | Stress responses
A laboratory study reported changes in reactive oxygen species and cell death in several cell models. These are cellular measurements, not memory-test results in patients. [1]
RAT MODEL | Specific conditions
Another experiment used a prenatal metabolic-stress model in rats and reported changes in offspring learning and neuronal stress responses. That is a specific animal setting. [2]
Patient benefit remains unresolved
The cited experiments do not establish a safe, effective human memory treatment. Cognitive outcomes, long-term safety and independent replication need their own evidence. [1] [2]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Khavinson et al. (2011): Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes →Pinealon/EDR identity and measured cellular responses.
- Arutjunyan et al. (2012): Pinealon protects the rat offspring from prenatal hyperhomocysteinemia →A specific prenatal metabolic-stress model, not a trial in people.
